Evidence map›Paper›PMID 30117276›Full record

ArticlePigment cell & melanoma research2019

Analysis of the putative tumor suppressor gene cdkn2ab in pigment cells and melanoma of Xiphophorus and medaka.

Janine Regneri, Barbara Klotz, Brigitta Wilde, Verena A Kottler, Michael Hausmann, Susanne Kneitz, Martina Regensburger, Katja Maurus, Ralph Götz, Yuan Lu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Pigment cell & melanoma research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. High frequency of melanoma inTheranostics · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Janine RegneriPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Barbara KlotzPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.ORCID 0000-0002-4988-3575
Brigitta WildePhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Verena A KottlerPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Michael HausmannPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Susanne KneitzPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Martina RegensburgerPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.
Katja MaurusInstitute of Pathology, University of Würzburg, Würzburg, Germany.
Ralph GötzDepartment of Biotechnology and Biophysics, University of Würzburg, Würzburg, Germany.
Yuan LuDepartment of Chemistry & Biochemistry, Molecular Biosciences Research Group, Texas State University, San Marcos, Texas.ORCID 0000-0002-2420-4804
Ronald B WalterDepartment of Chemistry & Biochemistry, Molecular Biosciences Research Group, Texas State University, San Marcos, Texas.
Amaury HerpinINRA, Fish Physiology and Genomics Institute (INRA-LPGP), Sexual Differentiation and Oogenesis Group (SDOG), Campus de Beaulieu, Rennes Cedex, France.
Manfred SchartlPhysiological Chemistry, University of Würzburg, Biozentrum, Würzburg, Germany.ORCID 0000-0001-9882-5948
University of Würzburg · DETexas State University · USLaboratoire de Physiologie et Génomique des Poissons · FR

Funding

Development of Aquatic Model Resources for Therapeutic ScreensR24OD018555 · OD · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2014 to 2017
$2.6M
NIH HHS R24 OD018555
6 · The paper itself

Abstract

In humans, the CDKN2A locus encodes two transcripts, INK4A and ARF. Inactivation of either one by mutations or epigenetic changes is a frequent signature of malignant melanoma and one of the most relevant entry points for melanomagenesis. To analyze whether cdkn2ab, the fish ortholog of CDKN2A, has a similar function as its human counterpart, we studied its action in fish models for human melanoma. Overexpression of cdkn2ab in a Xiphophorus melanoma cell line led to decreased proliferation and induction of a senescence-like phenotype, indicating a melanoma-suppressive function analogous to mammals. Coexpression of Xiphophorus cdkn2ab in medaka transgenic for the mitfa:xmrk melanoma-inducing gene resulted in full suppression of melanoma development, whereas CRISPR/Cas9 knockout of cdkn2ab resulted in strongly enhanced tumor growth. In summary, this provides the first functional evidence that cdkn2ab acts as a potent tumor suppressor gene in fish melanoma models.

Indexed as

Genes, Tumor SuppressorAnimalsCarcinogenesisCyclin-Dependent Kinase Inhibitor p16CyprinodontiformesEvolution, MolecularGene Expression Regulation, NeoplasticGene Knockout TechniquesMelanocytesMelanoma, ExperimentalMultigene FamilyOryziasPhenotypePhylogenyCyclin-Dependent Kinase Inhibitor p16cell cycle regulationnevip16/INK4Asenescencexmrk

Identifiers

PMID30117276
PMCPMC6377863
OpenAlexW2885361352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.